Guardant Health, Inc. - Bathi resik saben saham sajrone 12 wulan pungkasan GH

Guardant Health, Inc. (GH) is integrating Shield tests into medical practice, utilizing liquid biopsy for early cancer detection. The rolling annual earnings per share trend captures this trajectory, where the value of -3.68 expresses the metric level. Management is investing in research with scientific passion, aiming to update treatment protocols. Systems are currently scaling, establishing a foundation to become a cash cow despite significant R&D expenditures.

GH Bathi resik saben saham sajrone patang kuartal pungkasan Guardant Corp (04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan Guardant Health Inc (GH)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Guardant Health, Inc.|GH - Bagan rega target

- rincian nilai pasar emiten:

Biji pasar Guardant Health, Inc.|GH - Total Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Aset Bersih saben Siji Saham Guardant Health|GH - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku guardanthealth.com|GH - Gunggung Aset Perusahaan

- rincian utang lan likuiditas:

Utang marang Ekuitas Guardant Health, Inc.|GH - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Guardant360|GH - Tanggungan utang total perusahaan|Utang marang nilai buku Guardant Health, Inc.|GH - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Guardant Health|Likuiditas cepet guardanthealth.com

- data bathi lan kelipatan valuasi:

GH - Bathi pungkasan|Proyeksi bathi mangsa ngarep Guardant Health, Inc.|GH - Pangali rega marang bathi|Pangali Forward P/E Guardant Health|GH - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Guardant Health, Inc.|GH - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Guardant Health|GH - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan guardanthealth.com|GH - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Guardant Health, Inc.

Analisis komprehensif perusahaan:Guardant Health, Inc. - GH

To identify fundamental benchmarks in Guardant Health, Inc. (GH) financial statements, investors must analyze real returns adjusted for capital dilution. The current trailing 12-month EPS reflects the final earnings per share, allowing for a comparison of this liquid biopsy pioneer's efficiency against industry peers and an assessment of how scientific leadership in cancer diagnostics translates into the business's financial stability.

Pesaing Guardant Health, Inc. (GH)